Free Shipping on purchases over €100

Xpower Prolong Retardant Gel 75 Ml

Edible topical gel with peppermint and oatmeal that cools and decreases sensitivity to delay ejaculation and improve control, prolonging the enjoyment of intimate intercourse.

SKU: XP3760273959814
Sold out
Promo FD
16.10
€25.99
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Prolong Gel is intended to improve sexual intercourse. This gel helps to better control ejaculations thanks to its natural ingredients such as mint. Controlling your ejaculation well is at the heart of satisfying sexual relations, Prolong Gel accompanies you in this control of enjoyment.

Prolong Gel has been developed to improve men's sexual performance by delaying ejaculation. Prolong Gel works thanks to its active ingredients:

  • Peppermint will have an anaesthetic effect through its cooling action.
  • Oats will reduce the sensitivity of the nerves.
  • 75ml

Instructions for use:

  • Apply the gel to the penis before intercourse and massage until absorbed. Before using this product, test a small amount of gel on the forearm. Discontinue use if an allergic reaction occurs. External use. Keep out of reach of children. Store in a cool, dry place away from light. Kissable and condom compatible.

Ingredients

  • Aqua, PEG-7 Glyceryl Cocoate, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Carbomer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium hydroxide, Caprylyl glycol, 1,2-hexanediol, glycérin, alcool, Ethylhexylglycerin, Mentha Piperita Oil, Humulus Lupulus Cone Extract, Tropolone, Avena Sativa Kernel Extract, Limonene, Tocopherol.
Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.